SleepRes, Inc. — SEC Form D Filing

SleepRes, Inc. filed an SEC Form D on June 24, 2026, reporting $6.00M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 24, 2026
Amount reported
$6.00M
Round stage
Seed
Industry
Medical Devices
Website
https://sleepres.com/

What the company does

Securities: Debt. Exemption: Rule 506(c). Incorporated: DELAWARE

Problem

Existing Positive Airway Pressure (PAP) therapy for sleep apnea uses a pressure delivery model that has remained largely unchanged for decades, leading to poor patient adherence, with up to 50% of patients not meeting the one-year adherence threshold.

Solution

SleepRes is reimagining pressure delivery for sleep apnea with Kairos Positive Airway Pressure (KPAP), a new approach that delivers the right pressure at the right time, working with natural breathing, available on the Kricket™ device.

Why now

There is a growing demand for more comfortable and user-friendly solutions for sleep apnea treatment as patient adherence to traditional CPAP remains a significant challenge, driving innovation in respiratory medical technology.

Verdict

Investors backed this because the solution directly addressed a well-documented patient adherence problem in a massive, established market, not because it represented a fundamentally new diagnostic approach. The implicit bet was on a superior delivery mechanism materially improving long-term device adoption and recurring revenue. Upside was limited by the need for extensive clinical validation and the slow adoption cycle inherent to regulated medical device markets.

Source: SEC EDGAR Form D filing